Skip directly to content

Patient Organisation funding and support

Transparency is at the heart of our approach when working with patient organisations, and the interests of patients always come first.

In providing funding or working with patient organisations, Pfizer’s guiding principle is to ensure that the organisation’s independence is never compromised. If this is put at risk, then credibility starts to be lost on both sides and this helps no one. We feel passionately that relationships with patient organisations are both valuable and essential, and by operating with a high degree of transparency, we can be confident and proud of the relationships we have developed.

As a member of The Association of the British Pharmaceutical Industry (ABPI), we must declare a list of patient organisations to which we provide financial support and/or significant non-financial support, including a description of the support and its monetary value. For significant non-financial support which cannot be assigned a meaningful monetary value, we are required to describe clearly the value that the organisation receives.

We are also required to provide a list of patient organisations we have engaged to provide significant contracted services, including a description of the services provided.

In addition, we disclose the payment of expenses relating to accommodation and travel (both in the UK and abroad) incurred by patient organisations in the course of their interaction with us. Our disclosure of expenses payments for patient organisations includes both out-of-pocket expenses reimbursed to patient groups, and expenses paid in advance by Pfizer.

We are always mindful of the potential to create an over-dependency on any funding we provide. That is why, wherever possible, we report the percentage of each patient organisation’s revenue that our funding makes up.

However, there are times when this percentage may be higher than average. This might be due to a difficult fundraising climate, because an organisation is new or small in size, or perhaps experienced some unforeseen circumstances that impacted on its ability to attract income. Where this is the case, we actively encourage the organisation to seek and secure other sources of sustainable funding in line with the guidelines outlined in the ABPI Code of Practice.

 

Patient organisation disclosure reports

PP-PFE-GBR-0574 / August 2017